Skip Navigation

Center for Immunization Research

Left Background
 

Malaria Vaccine Trials at the CIR

The CIR’s experience conducting clinical trials with malaria vaccine candidates is notable, including the:

  • R32Ns1 sporozoite vaccine
  • P. falciparum CSP non-repeating vaccine antigen (NS81RLF) in MPL/CWS adjuvant
  • P. falciparum CSP non-repeating vaccine antigen (NS81RLF) in liposomal adjuvant
  • Pvs25H, a transmission-blocking vaccine for P. vivax
  • AMA1-C1/Alhydrogel with and without CPG7909, an asexual blood-stage vaccine for P. falciparum
  • PpPfs25/ISA51, a transmission-blocking vaccine for P. falciparum
  • ScPvs25/ISA, a transmission-blocking vaccine for P. vivax
  • MSP142-C1/Alhydrogel with and without CPG7909, an asexual blood-stage vaccine for P. falciparum

Here is a link to a list of selected publications by CIR faculty about malaria.

   Topics

Malaria

Malaria Vaccine Trials